Tumor necrosis factor-alpha enhances cytokine production by AML blasts.
Murohashi
I
I
Clinical Research Institute of Montreal, Canada.
Rodriguez-Cimadevilla
J C
JC
Hoang
T
T
D001752:Blast Crisis / Q000503:physiopathology*; D002478:Cells, Cultured; D016207:Cytokines / Q000235:genetics*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics / Q000494:pharmacology; D006801:Humans; D007375:Interleukin-1 / Q000235:genetics; D007377:Interleukin-3 / Q000494:pharmacology; D007700:Kinetics; D015470:Leukemia, Myeloid, Acute / Q000473:pathology*; D014158:Transcription, Genetic / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D016207:Cytokines; D007375:Interleukin-1; D007377:Interleukin-3; D014409:Tumor Necrosis Factor-alpha; D016178:Granulocyte-Macrophage Colony-Stimulating Factor